Company / Gross Profit per Share
Halozyme Gross Profit per Share History
FY2016-FY2019 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Gross Profit per Share
$0.03
FY2019
5-year range
-
FY2016-FY2019
Trend
-1.5%
vs FY2018
Sector context
#30 of 29
Health Care
What the data says
Among 29 Health Care companies, Halozyme is in the bottom -3% for gross profit per share. Declined from $0.03 to $0.03 over the past 2 years.
Based on SEC 10-K filings.
0.03 in FY2019 with a 3-year CAGR of -0.5%.
Declined from $0.03 to $0.03 over the past 2 years.
Health Care sector context is included.
Gross Profit per Share over time
Growth rates
- 3-Year CAGR
- -0.5%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom -3% in Health CareTop 103% of 29This company $0.03 Sector average $8.11
▼
-99.7% below sector average
Key checks
Key Insights
- In FY2019, gross profit per share decreased 1.5% year-over-year.
- Ranks #30 out of 29 companies in the Health Care sector.
Company context
Key Data Points
- Strong profit margin: 47.9%
- High earnings quality (cash-backed earnings)
- Strong return on equity: 118.2%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Gross Profit per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | - | - |
| FY2022 | - | - |
| FY2021 | - | - |
| FY2020 | - | - |
| FY2019 | $0.03 | -1.5% |
| FY2018 | $0.03 | -12.6% |
| FY2017 | $0.03 | +14.4% |
| FY2016 | $0.03 | -1.9% |
As of FY2019 · SEC 10-K · Updated Jun 30, 2026